This study introduces CK21, a novel pro-drug of triptolide, which demonstrates potent anti-proliferative effects on pancreatic cancer by inhibiting the NF-κB pathway, increasing oxidative stress, and inducing mitochondrial-mediated apoptosis, while showing minimal toxicity. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.